Patent details

Basic Information

Publication number:

EP3258935

PCT Application Number:

US2016018316

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167100387

PCT Publication Number:

WO2016134049

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ILOPERIDONE FOR THE TREATMENT OF SCHIZOPHRENIA

French Title of Invention:

ILOPÉRIDONE POUR LE TRAITEMENT DE LA SCHIZOPHRÉNIE

German Title of Invention:

LOPERIDON ZUR BEHANDLUNG VON SCHIZOPHRENIE

SPC Number:

Dates

Filing date:

17/02/2016

Grant date:

07/04/2021

EP Publication Date:

27/12/2017

PCT Publication Date:

25/08/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/04/2021

EP B1 Publication Date:

07/04/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/02/2022

Expiration date:

17/02/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/03/2021

 

 

Name:

Vanda Pharmaceuticals Inc.

Address:

2200 Pennsylvania Avenue Suite 300-E, Washington, DC 20037, United States (US)

Inventor

1

Name:

POLYMEROPOULOS, Mihael H.

Address:

United States (US)

2

Name:

WOLFGANG, Curt D.

Address:

United States (US)

Priority

1

Priority Number:

201562117173 P

Priority Date:

17/02/2015

Priority Country:

United States (US)

2

Priority Number:

201562172436 P

Priority Date:

08/06/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/454; A61P 25/18;

Publication

European Patent Bulletin

Issue number:

202114

Publication date:

07/04/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages